Neoclone
About:
Neoclone is a research-focused company with an emphasis on emerging antibody technologies.
Website: https://www.neoclone.com
Top Investors: National Institutes of Health, Wisconsin Investment Partners, Silicon Pastures
Description:
Neoclone is a research-focused company with an emphasis on emerging antibody technologies. NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the need for better ways to discover and develop antibodies.
Total Funding Amount:
$1.95M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Madison, Wisconsin, United States
Founded Date:
1999-01-01
Founders:
Mark Jackson
Number of Employees:
11-50
Last Funding Date:
2016-05-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai